170856-87-8Relevant articles and documents
BCL-2 INHIBITORS AND THEIR USE AS PHARMACEUTICALS
-
Paragraph 0457-0458, (2021/11/13)
The disclosure is directed to, in part, to BCL-2 inhibitors, pharmaceutical compositions comprising the same, as well as methods of their use and preparation.
ACYLSULFONAMIDE DERIVATIVES FOR TREATING SENESCENCE-ASSOCIATED DISEASES AND DISORDERS
-
Paragraph 0284; 0285, (2017/07/14)
Compounds represented by Formula (I) and (II) and salts thereof are described herein. The compounds or salts of Formula (I) and (II) may be used to treat senescence-associated diseases and disorders.
G-PROTEIN COUPLED RECEPTOR AGONISTS
-
Page/Page column 33-34, (2008/06/13)
Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.